Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online September 11, 2007
Diabetes Care 30:3070-3076, 2007
DOI: 10.2337/dc07-0895
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-0895v1
30/12/3070    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Villar, E.
Right arrow Articles by McDonald, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Villar, E.
Right arrow Articles by McDonald, S. P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Research

Incidences, Treatments, Outcomes, and Sex Effect on Survival in Patients With End-Stage Renal Disease by Diabetes Status in Australia and New Zealand (1991–2005)

Emmanuel Villar, MD, PHD1,2, Sean Haw Chang, MBBS, MRCP1,3 and Stephen Peter McDonald, MBBS, FRACP, PHD1,3

1 Australia and New Zealand Dialysis and Transplant Registry, Woodville, South Australia, Australia
2 Department of Nephrology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Benite, France
3 Department of Nephrology, The Queen Elizabeth Hospital, Woodville, South Australia, Australia, and University of Adelaide, Adelaide, South Australia, Australia

Address correspondence and reprint requests to Emmanuel Villar, MD, PhD, ANZDATA Registry, The Queen Elizabeth Hospital, 28 Woodville Rd., Woodville South, South Australia 5011, Australia. E-mail: emmanuel.villar{at}anzdata.org.au

OBJECTIVE—We aimed to update the epidemiology of type 1 and type 2 diabetic patients among the incident end-stage renal disease (ESRD) population in Australia and New Zealand (ANZ) and to determine whether outcome is worse for diabetic women, as described in the general population.

RESEARCH DESIGNS AND METHODS—All resident adults of ANZ who began renal replacement therapy (RRT) from 1 April 1991 to 31 December 2005 were included using data from the ANZ Dialysis and Transplant Registry. Incidence rates, RRT, and survival were analyzed. Risk factors for death were assessed using Cox regression.

RESULTS—The study included 1,284 type 1 diabetic (4.5%), 8,560 type 2 diabetic (30.0%), and 18,704 nondiabetic (65.5%) patients. The incidence rate of ESRD with type 2 diabetes increased markedly over time (+10.2% annually, P < 0.0001). In patients aged <70 years, rates of renal transplantation in type 1 diabetic, type 2 diabetic, and nondiabetic patients were 41.8, 6.5 (P < 0.0001 vs. other patients), and 40.9% (P = 0.56 vs. type 1 diabetic patients), respectively. Compared with nondiabetic patients, the adjusted hazard ratio (HR) for death was 1.64 (P < 0.0001) in type 1 diabetes and 1.13 (P < 0.0001) in type 2 diabetes. Survival rates per 5-year period improved by 6% in type 1 diabetic patients (P = 0.36), by 9% in type 2 diabetic patients (P < 0.0001), and by 5% in nondiabetic patients (P = 0.001). In type 2 diabetic patients aged ≥60 years, the adjusted HR for death in women versus men was 1.19 (P = 0.0003).

CONCLUSIONS—The incidence of ESRD with type 2 diabetes increased markedly. Despite high access to renal transplants, type 1 diabetic patients had a poor prognosis after starting RRT. Survival improved significantly in type 2 diabetic patients during the study period. Older type 2 diabetic women had a worse prognosis than older type 2 diabetic men.

Abbreviations: ANZ, Australia and New Zealand • ANZDATA, Australia and New Zealand Dialysis and Transplant Registry • eGFR, estimated glomerular filtration rate • ESRD, end-stage renal disease • RRT, renal replacement therapy • RTx, renal transplantation


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
E. Villar and M. Labeeuw
Relative mortality risk in chronic kidney disease and end-stage renal disease: the effect of age, sex and diabetes
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1770 - 1771.
[Full Text] [PDF]


Home page
CJASNHome page
S. H. Chang, T. H. Mathew, and S. P. McDonald
Analgesic Nephropathy and Renal Replacement Therapy in Australia: Trends, Comorbidities and Outcomes
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 768 - 776.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.